Search bioRxiv⌕ Search

Biology subjects

Crow, J.

Publications and source records attributed to Crow, J..

2 recordsLinked to original sources

Spatial and single-cell transcriptomics capture two distinct cell states in plant immunity

Unlike animals, plants are sessile organisms that must adapt to localized and fluctuating environmental stimuli, including abiotic and biotic stresses. While animals use mobile immune cells to eliminate pathogens, plants rely on localized cells in contact with the pathogen to detect and mount immune responses. Although bulk RNA sequencing (RNA-seq) has enabled the assessment of plant responses to pathogen infection at the whole transcriptome level, the spatial coordination of plant immune responses remains elusive. In this study, we performed both spatial and single-nuclei transcriptomic experiments to capture the spatial pattern of soybean plant responses to Asian soybean rust infection caused by the pathogen Phakopsora pachyrhizi. Through the analysis of both spatial and single-nuclei transcriptomics data, we identified two distinct host cell states with specific spatial localization in response to pathogen infection: the infected regions with the presence of the pathogen and the surrounding regions bordering the infected regions. Importantly, the surrounding regions exhibited higher expression of defense response-related genes than the infected regions, despite having minimal presence of the pathogen, indicating a cell non-autonomous defense response in the surrounding regions. Additionally, gene co-expression network analysis with single-cell resolution identified a key immune response-related gene module activated in the stressed cells captured in our single-nuclei RNA-seq data. This study reveals the intricate spatial coordination of plant defense responses against pathogen infection and enhances our understanding of the importance of localized cell non-autonomous defense responses in plant-pathogen interactions.

plant biology↗

Seclidemstat blocks the transcriptional function of multiple FET-fusion oncoproteins

Genes encoding the RNA-binding proteins FUS, EWSR1, and TAF15 (FET proteins) are involved in chromosomal translocations in rare sarcomas. FET-rearranged sarcomas are often aggressive malignancies affecting patients of all ages. New therapies are needed. These translocations fuse the 5 portion of the FET gene with a 3 partner gene encoding a transcription factor (TF). The resulting fusion proteins are oncogenic TFs with a FET protein low complexity domain (LCD) and a DNA binding domain. FET fusion proteins have proven stubbornly difficult to target directly and promising strategies target critical co-regulators. One candidate is lysine specific demethylase 1 (LSD1). LSD1 is recruited by multiple FET fusions, including EWSR1::FLI1. LSD1 promotes EWSR1::FLI1 activity and treatment with the noncompetitive inhibitor SP-2509 blocks EWSR1::FLI1 transcriptional function. A similar molecule, seclidemstat (SP-2577), is currently in clinical trials for FET-rearranged sarcomas (NCT03600649). However, whether seclidemstat has pharmacological activity against FET fusions has not been demonstrated. Here, we evaluate the in vitro potency of seclidemstat against multiple FET-rearranged sarcoma cell lines, including Ewing sarcoma, desmoplastic small round cell tumor, clear cell sarcoma, and myxoid liposarcoma. We also define the transcriptomic effects of seclidemstat treatment and evaluated the activity of seclidemstat against FET fusion transcriptional regulation. Seclidemstat showed potent activity in cell viability assays across FET-rearranged sarcomas and disrupted the transcriptional function of all tested fusions. Though epigenetic and targeted inhibitors are unlikely to be effective as a single agents in the clinic, these data suggest seclidemstat remains a promising new treatment strategy for patients with FET-rearranged sarcomas. SIGNIFICANCEHere, we show the noncompetitive inhibitor, seclidemstat, has in vitro activity against multiple FET fusion proteins that cause a number of rare and aggressive sarcomas. These data represent one of the largest analyses of FET fusion activity across multiple malignancies and are a valuable resource for those studying FET-rearranged sarcomas.

cancer biology↗